Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arcoxia for Preventing Heterotopic Ossification After THA
NCT01022190Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2009
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of etoricoxib in heterotopic ossification (HO), sponsored by Radboud University Medical Center. Started Dec 2009; status: completed.
02
Drugs
etoricoxib
03
Conditions
heterotopic ossification (HO)
Beyond the preview
Go deeper on NCT01022190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01022190.